Skip to main content

Parikh Anand Kiran's Form 4 filing

Faeth Therapeutics, Inc. (FTH) · filed Jun 24, 2026

Accession no.
0002111813-26-000010
Filed
Jun 24, 2026
Trade date
Jun 22, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $55.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Parikh Anand KiranCIK 0002111813Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 22, 2026Common StockPPurchaseAcquired+2,806$19.76+$55,446.56764,234Direct
Jun 22, 2026Common StockMOption exerciseAcquired+45,252$1.16+$52,492.32809,486Direct
Jun 22, 2026Common StockMOption exerciseAcquired+8,213$1.16+$9,527.08817,699Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 22, 2026Common StockMOption exerciseDisposed−45,252$0.00$091,632Direct
Jun 22, 2026Common StockMOption exerciseDisposed−8,213$0.00$04,107Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)